PERSPECTIVE article
Front. Med.
Sec. Hepatobiliary Diseases
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1609816
This article is part of the Research TopicHot Topics in Diabetes and Steatotic Liver DiseaseView all 10 articles
1990-2021 Global, Regional, and National Analysis of the Burden and Trends of Non-Alcoholic Fatty Liver Disease
Provisionally accepted
- Shaanxi University of Chinese Medicine, Xianyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background NAFLD, a leading global cause of liver disease, is projected to dominate end-stage liver disease burden. Strongly linked to obesity, type 2 diabetes, and metabolic syndrome, its prevalence and incidence are rising rapidly, yet it remains unclassified by WHO as a priority non-communicable disease.This study aims to assess the global, regional, and national burden of NAFLD from 1990 to 2021 and provide evidence for future prevention and control strategies.Using 2021 Global Burden of Disease (GBD) data, this study analyzed NAFLD prevalence, incidence, mortality, and disability-adjusted life years (DALYs) across 204 countries (1990-2021), stratified by sex, age, and Socio-demographic Index (SDI). Trends were assessed via age-standardized rates (ASR) and estimated annual percentage changes (EAPC), with projections to 2050. Results .In 2021, global NAFLD cases surged to 1.268 billion (124.63% increase since 1990), while ASR rose from 12,085.09 to 15,018.07 per 100,000. Middle-and high-SDI regions exhibited steepest rises in incidence and mortality. Oceania, Central and Latin America had highest prevalence; North Africa and the Middle East reported peak incidence. Projections indicate escalating global incidence through 2050, disproportionately affecting females, driven by population growth and aging.The escalating burden underscores urgent need for region-specific interventions, particularly in aging and high-growth populations. Enhanced screening and early intervention are critical to mitigate NAFLD's expanding impact. This study highlights actionable data to inform global public health strategies, emphasizing tailored prevention and control measures to address evolving epidemiological trends.
Keywords: Non-alcoholic fatty liver disease, Prevalence, Incidence, Mortality, Disability-adjusted life years, socio-demographic index, Epidemiological trends, Future projections
Received: 11 Apr 2025; Accepted: 26 May 2025.
Copyright: © 2025 Tang, Zheng, Yan, Zhang and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiao-Mei Ren, Shaanxi University of Chinese Medicine, Xianyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.